Teva Pharmaceutical Industries Ltd (TEVA) Decline: Is It Certain
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Why Is Teva Pharmaceutical Industries Ltd (TEVA) Stock Lagging Behind -5.15% from Its 50-Day SMA?
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Teva Pharmaceutical Industries Ltd (TEVA) Stock: More Strategic Than Meets the Eye
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Teva Pharmaceutical Industries Ltd (TEVA) Stock: Greater Than Its Current Valuation?
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Why Is Teva Pharmaceutical Industries Ltd (TEVA) Stock Surpassing 15.12% from Its 50-Day SMA?
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Teva Pharmaceutical Industries Ltd (TEVA) Stock: Surpassing Expectations in the Market?
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Teva Pharmaceutical Industries Ltd (TEVA) Stock: Understanding Its Underlying Value
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Why Did Teva Pharmaceutical Industries Ltd (TEVA) Stock See 24.73% Surge in the Last 90 Days?
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Why Teva Pharmaceutical Industries Ltd (TEVA) Stock is Currently 19.33% Above from Its 20-Day SMA?
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]
Teva Pharmaceutical Industries Ltd (TEVA) Stock’s 1.05% Increase This Year: What’s the Story?
Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $14. Piper Sandler also raised Overweight rating with a price target of […]